A second, cheaper, malaria vaccine has been approved by the World Health Organistion for global rollout. The R21 vaccine was jointly developed by America’s Novavax, India’s Serum Institute, and the University of Oxford in England. Stuart Smith has more from London.
Oct
03
Comments are closed.